GE HealthCare nears acquisition of Sofie Biosciences for $1 billion
GE HealthCare Technologies is reportedly in advanced discussions to acquire Sofie Biosciences for approximately $1 billion, according to the Financial Times. The deal would strengthen GE's position in radioactive diagnostic agents used in medical imaging. Sources indicate that negotiations are at an advanced stage but no official announcement has been made yet. The acquisition aligns with GE HealthCare’s strategy of expanding its portfolio in critical care and diagnostics. Sofie Biosciences specializes in developing radiopharmaceutical products, which could complement GE's existing offerings in medical imaging technologies.
Tickers: $GEHC